Protective effect of n-3 polyunsaturated fatty acid on primary culture of rat hepatocytes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 11, 2007, Pages 1965-1970

  Sohma, Ryoichi ^a   Takahashi, Morio ^a   Takada, Hiroshi ^a   Takada, Hironobu ^a   Kuwayama, Hajime ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Direct protective effect; Eicosapentaenoic acid; Primary biliary cirrhosis; Rat hepatocytes in primary culture; Superoxide dismutase

Indexed keywords

CHENODEOXYCHOLIC ACID; COLLAGENASE; COMPLEMENTARY DNA; COPPER ZINC SUPEROXIDE DISMUTASE; ICOSAPENTAENOIC ACID; LACTATE DEHYDROGENASE; LEUKOTRIENE B4; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; RNA; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASSAY; CELL DAMAGE; CELL ISOLATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; LIVER CELL; LIVER CELL CULTURE; LIVER PERFUSION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA EXTRACTION;

EID: 34948840883     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04684.x     Document Type: Article

References (23)

1. Leaf A, Weber PC. A new era for science in nutrition. Am. J. Clin. Nutr. 1987 45 (5 Suppl. 1048 53.
2. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978 2 : 117 19.
3. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest. 1984 74 : 1922 33.
4. Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. USA 1983 80 : 3581 4.
5. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med. Scand. 1980 208 : 401 6.
6. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979 2 : 433 5.
7. Kremer JM, Jubiz W, Michalek A et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann. Intern. Med. 1987 106 : 497 503.
8. Ziboh VA, Cohen KA, Ellis CN et al. Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Arch. Dermatol. 1986 122 : 1277 82.
9. Salomon P, Kornbluth AA, Janowitz HD. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J. Clin. Gastroenterol. 1990 12 : 157 61.
10. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N. Engl. J. Med. 1996 334 : 1557 60.
11. Walton AJ, Snaith ML, Locniskar M, Cumberland AG, Morrow WJ, Isenberg DA. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 1991 50 : 463 6.
12. Kaplan MM. Primary biliary cirrhosis - a first step in prolonging survival. N. Engl. J. Med. 1994 330 : 1386 7.
13. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OF. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J. Hepatol. 1992 15 : 336 44.
14. Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991 101 : 1332 8.
15. Takada H, Takahashi M, Kitazumi Y et al. Clinical efficacy of eicosapentate on the laboratory data of primary biliary cirrhosis patients. Digestive Disease Week AASLD 2000 : 23.
16. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976 13 : 29 83.
17. Miyazaki K, Nakayama F, Koga A. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Dig. Dis. Sci. 1984 29 : 1123 30.
18. Greim H, Czygan P, Schaffner F, Popper H. Determination of bile acids in needle biopsies of human liver. Biochem. Med. 1973 8 : 280 6.
19. Lee TH, Hoover RL, Williams JD et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985 312 : 1217 24.
20. Beyer W, Imlay J, Fridovich I. Superoxide dismutases. Prog. Nucl. Acid. Res. Mol. Biol. 1991 40 : 221 53.
21. Benito S, Fernandez Y, Mitjavila S, Moussa M, Anglade F, Periquet A. Phospholipid fatty acid composition affects enzymatic antioxidant defenses in cultured Swiss 3T3 fibroblasts. Redox Rep. 1997 3 : 281 6.
22. Ono M, Sekiya C, Ohhira M et al. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis. J. Lab. Clin. Med. 1991 118 : 476 83.
23. Chen LY, Lawson DL, Mehta JL. Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb. Res. 1994 76 : 317 22.